These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 641153)

  • 21. Glucagon immunoreactivity and chromatographic profiles in pancreatectomized humans. Paradoxical response to oral glucose.
    Bajorunas DR; Fortner JG; Jaspan JB
    Diabetes; 1986 Aug; 35(8):886-93. PubMed ID: 3525286
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunologic characterization of plasma glucagon components in a patient with malignant glucagonoma.
    Tanaka K; Watabe T; Shimizu N; Horiuchi T; Nakamura K; Yoshida H
    Metabolism; 1984 Aug; 33(8):728-33. PubMed ID: 6087085
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Plasma glucagon and insulin in rat pregnancy. Roles in glucose homeostasis.
    Saudek CD; Finkowski M; Knopp RH
    J Clin Invest; 1975 Jan; 55(1):180-7. PubMed ID: 1109177
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The peculiar processing of glucagon and glucagon-related peptides in patients after pancreatectomy.
    Tanjoh K; Tomita R; Hayashi N
    Hepatogastroenterology; 2002; 49(45):825-32. PubMed ID: 12064000
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The glucagonoma syndrome: stimulus-induced plasma responses of circulating glucagon components IRG9000 and IRG3500.
    Hendriks T; Jansen JB; van Tongeren JH
    Acta Endocrinol (Copenh); 1984 Feb; 105(2):226-32. PubMed ID: 6141691
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential immunoreactivity of plasma glucagon components in man: studies with different glucagon antibodies.
    Soybel D; Jaspan J; Polonsky K; Goldberg I; Rayfield E; Tager H
    J Clin Endocrinol Metab; 1983 Mar; 56(3):612-8. PubMed ID: 6185527
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Glucagon immunoreactivity and antidiabetic action of somatostatin in the totally duodeno-pancreatectomized and gastrectomized human.
    Bringer J; Mirouze J; Marchal G; Pham TC; Luyckx A; Lefebvre P; Orsetti A
    Diabetes; 1981 Oct; 30(10):851-6. PubMed ID: 6115786
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Studies of glucose intolerance in cirrhosis of the liver.
    Shankar TP; Solomon SS; Duckworth WC; Himmelstein S; Gray S; Jerkins T; Bobal MA; Iyer RS
    J Lab Clin Med; 1983 Oct; 102(4):459-69. PubMed ID: 6352838
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The relationship of plasma glucagon to the hyperglycaemia and hyperinsulinaemia of surgical operation.
    Giddings AE; O'Connor KJ; Rowlands BJ; Mangnall D; Clark RG
    Br J Surg; 1976 Aug; 63(8):612-6. PubMed ID: 953465
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Elevated pancreatic glucagon in obesity.
    Starke AA; Erhardt G; Berger M; Zimmermann H
    Diabetes; 1984 Mar; 33(3):277-80. PubMed ID: 6365661
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of adrenergic blockade on the glucagon responses to starvation and hypoglycemia in man.
    Walter RM; Dudl RJ; Palmer JP; Ensinck JW
    J Clin Invest; 1974 Nov; 54(5):1214-20. PubMed ID: 4153713
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunoreactive glucagon (IRG) responses to intravenous glucose in prediabetes and diabetes among Pima Indians and normal Caucasians.
    Aronoff SL; Bennett PH; Unger RH
    J Clin Endocrinol Metab; 1977 May; 44(5):968-72. PubMed ID: 870519
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chemical characterization of persistent immunoreactive glucagon in eviscerated rats.
    Wider MD; Dunbar JC
    Acta Diabetol Lat; 1984; 21(4):341-8. PubMed ID: 6549365
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A functional study of a case of glucagonoma exhibiting typical glucagonoma syndrome.
    Fujita J; Seino Y; Ishida H; Taminato T; Matsukura S; Horio T; Imamura S; Naito A; Tobe T; Takahashi K
    Cancer; 1986 Feb; 57(4):860-5. PubMed ID: 2867823
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Plasma pancreatic glucagon in pancreatic and primary diabetes, and liver cirrhosis: application of a correction to the radioimmunoassay for pancreatic glucagon.
    Okumura N; Hayakawa T; Yasui K; Noda A; Kondo T; Otsuka K; Nimura Y
    Gastroenterol Jpn; 1982; 17(4):347-52. PubMed ID: 7141199
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transhepatic glucagon gradients in man: evidence for glucagon extraction by human liver.
    Jaspan JB; Ruddick J; Rayfield E
    J Clin Endocrinol Metab; 1984 Feb; 58(2):287-92. PubMed ID: 6693539
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Degradation of [125I]iodoglucagon by normal rat plasma in radioimmunoassay mixture containing aprotinin and its prevention by p-chloromercuriphenyl sulfonate and leupeptin.
    Tsubouchi H; Miyazaki H; Gohda E; Nakayama H; Nakazono Y; Daikuhara Y; Hashimoto S
    Endocrinology; 1986 Sep; 119(3):1137-45. PubMed ID: 2426096
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lack of a "big plasma glucagon" response during arginine stimulation of glucagon secretion.
    von Schenck H; Vasquez B; Unger RH
    Horm Metab Res; 1982 Feb; 14(2):69-71. PubMed ID: 7068099
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Plasma immunoreactive glucagon fractions in four cases of glucagonoma: increased "large glucagon-immunoreactivity".
    Recant L; Perrino PV; Bhathena SJ; Danforth DN; Lavine RL
    Diabetologia; 1976 Aug; 12(4):319-26. PubMed ID: 183997
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The physicochemical nature and biological function of extrapancreatic immunoreactive glucagon.
    Ikei S; Mori K; Sakamoto Y; Ishii J; Watanabe O; Inoue M; Akagi M
    Gastroenterol Jpn; 1980; 15(3):241-6. PubMed ID: 7399222
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.